Mounjaro (tirzepatide) reduces blood pressure by an average of 5 to 8 mmHg, a clinically significant benefit for obese hypertensive patients.
Hypertension and obesity: a vicious cycle
Obesity is a major risk factor for hypertension. Each 10 kg of excess weight increases systolic blood pressure by 3 to 5 mmHg. The mechanism involves hyperactivation of the renin-angiotensin-aldosterone system, renal compression by perirenal fat, hyperinsulinemia, and increased cardiac output. Weight loss is therefore a major antihypertensive strategy.
Effect of tirzepatide on blood pressure
The SURMOUNT trials documented a significant reduction in blood pressure with tirzepatide: an average of -5.6 mmHg systolic and -3.8 mmHg diastolic at the 15 mg dose after 72 weeks. This reduction is clinically relevant: a 5 mmHg drop in systolic blood pressure reduces the risk of stroke by 14% and the risk of myocardial infarction by 9% according to Lancet meta-analyses.
Can antihypertensive treatment be reduced?
Some patients on tirzepatide see their blood pressure normalize to the point where they can reduce or discontinue their antihypertensive treatment. This decision must be made exclusively by a physician, with close monitoring of blood pressure (self-measurement recommended). Never modify your antihypertensive treatment without medical advice, even if your blood pressure seems low.
Track your progress with the MounjaGO app.
FAQ
What are the main recommendations for Mounjaro under GLP-1 treatment?
Key recommendations include regular medical follow-up, monitoring blood tests, adequate protein intake, and adapted physical activity. Consult your doctor for personalized advice for your situation.
Is tirzepatide (Mounjaro) effective for high blood pressure?
The SURMOUNT and SURPASS clinical trials have demonstrated the efficacy of tirzepatide in this indication, with significant documented results. Your doctor will assess the relevance of the treatment for your individual profile.
What side effects should be monitored in relation to Mounjaro?
Side effects to monitor depend on your personal situation. The most common are gastrointestinal disturbances (nausea, diarrhea, constipation). Report any unusual symptoms to your doctor for evaluation.
How does the MounjaGO app help with Mounjaro?
MounjaGO offers comprehensive tracking of injections, weight, side effects, and generates PDF reports for your consultations. This structured monitoring improves therapeutic adherence and communication with your doctor.